B-cell development occurs in a stepwise fashion that can be followed by the expression of B cell-specific surface markers. In this study, we wished to identify proteins that could contribute to the changes in expression of such markers. By using RNA from freshly isolated B220 þ cells, we hoped to reduce the effect of artifacts that occur during the isolation and amplification steps necessary to use flow cytometry analysis-sorted subsets in microarray experiments. Analyses comparing expression patterns from B220 þ 2-week bone marrow (pro-B, pre-B, immature B cells), 2-week spleen (predominantly transitional cells) and 8-week spleen (mainly mature B cells) yielded hundreds of genes. We also examined the B cell-activating factor (BAFF)-dependent effects on immature splenic B cells by comparing expression patterns in the spleen between 2-week A/J vs 2-week A/WySnJ mice, which lack functional BAFF receptor signaling. Genes that showed the expression differences between spleen and bone marrow samples were then analyzed through quantitative PCR on B-cell subsets isolated using two different sorting protocols. A comparison of the results from our study with the results from other analyses showed not only some overlap of preferentially expressed genes but also an expansion of other genes potentially involved in B-cell development.
Introduction
The development of the B-cell lineage initiates in the bone marrow when pro-B cells are generated from common lymphoid progenitor cells. 1 B cell-specific proteins such as the B-cell receptor (BCR), CD19, Pax5 and the B220 form of CD45 allow for the further maturation of the B cell into a pre-B cell phenotype. 2 Maturing B cells exit the marrow and colonize peripheral lymphatic tissues such as the spleen. 3, 4 Autoreactive B cells are eliminated, undergo receptor editing, or are anergized in the marrow 5, 6 and the spleen. 7, 8 The most immature B cells of the spleen, termed transitional 1 cells (T1), 9 are susceptible to B-cell receptor-dependent cell death/arrest. On the basis of the models proposed by Loder, 10 Allman 11 and others, T1 cells lead to another transitional intermediate, the transition 2 (T2) cell. The canonical B-cell differentiation pathway further suggests that marginal zone (MZ) cells and follicular mature (FM) cells are the direct descendents of T2 B cells. [10] [11] [12] This highly ordered pathway of marrow and splenic B-cell development relies upon a complex network of various environmental signals and transcription factor regulatory pathways. 13 The products of the mouse Cr2 (CD21) and Fcer2a (CD23) genes are widely used as cellular markers for differentiating splenic B-cell subsets. [14] [15] [16] Our lab has a long-standing interest in understanding the immune regulation and transcriptional control of the Cr2 and Fcer2a genes. These two genes are expressed during the same window of B-cell development at the T1-T2 transition phase, and their expression is extinguished following the loss of Pax5, which occurs as B cells mature into terminally differentiated plasma cells. 17, 18 The Cr2 and Fcer2a genes share a number of transcriptional control elements including those for Pax5, nuclear factor (NF)-kB, nuclear factor of activated T cells family members, E box protein E2A and the Notch signaling family member retinol binding protein-Jk. [19] [20] [21] [22] Mature B cells engineered to lack Pax5 (through a CD19-credependent deletion) show decreased expression of the CR1/CR2 proteins and CD23. 23 Earlier we have demonstrated that Pax5 binds equally to the Cr2 and Fcer2a genes in expressing mature splenic B cells as well as marrow B cells, which do not express Cr2 and Fcer2a. 19 This finding suggests that these two genes either lack a key activating transcription factor to allow their expression at the T1/T2 stages or are blocked from transcription in marrow B cells by a transcriptional silencing protein whose function is lost during B-cell differentiation.
In addition, it is known that the T1-T2 transition of splenic B cells is dependent upon the cell survival and maturation signals generated by the B cell-activating factor of the tumor necrosis factor family (BAFF). [24] [25] [26] [27] BAFF binding to its receptor, BAFF-R, induces activation of an alternative NF-kB signaling pathway (utilizing p52 homodimers) [28] [29] [30] [31] and downregulates the pro-apoptotic protein Bim through a heightened activation of extracellular signal-regulated kinase. 32 Animals deficient in BAFF or BAFF-R show a profound loss in peripheral mature B-cell populations, but B-cell development in the marrow and the migration of T1 B cells into the spleen are not altered. 15, 24, 27 The BAFF-R mutant A/WySnJ mouse possesses a mutation within the cytoplasmic tail of this receptor that eliminates its ability to bind to the intracellular signaling molecule tumor necrosis factor receptor-associated factor 3. [33] [34] [35] [36] [37] These mice have deficiencies in T2, MZ and FM B-cell populations but their bone marrow B-cell developmental stages and splenic T1 populations are normal and similar to those of BAFFdeficient animals. 24, 27 The expression of Cr2 and Fcer2a has been suggested to be a direct effect of BAFF signaling independent of the B-cell survival function of the cytokine 16 (presumably through the enhanced translocation of NF-kB-p52 into the nucleus). However, we have found BAFF-dependent expression levels of CD21 and CD23 to be similar to those of CD19 and other B-cell marker proteins whose expression is not directly dependent upon NF-kB-p52. Furthermore, NF-kB-p52 chromatin complexes are evident within Cr2 and Fcer2a genes from BAFF-R-defective and normal B cells. 38 In this study, we sought to identify the key transcriptional regulatory proteins that control Cr2 and Fcer2a expression during B-cell maturation. We utilized cells from wild-type A/J bone marrow, immature spleen and mature spleen to create overlapping genomic screens to identify gene products preferentially lost or enhanced during B-cell development. This approach allowed us to enrich for populations that vary in their expression of CD21 and CD23 instead of isolating marrow and splenic B-cell subsets and using amplification to obtain enough RNA. We also compared A/J mice with the mutant A/ WySnJ to investigate the downstream targets/genes of BAFF signaling that could contribute to CD21 and CD23 expression. We have identified a number of immunomodulatory proteins whose expression and function are linked to B-cell development by obtaining gene grid array data from a variety of similar models and comparing those data with known positive and negative controls for appropriate expression profiles. This list of candidate proteins includes numerous transcription factors that could control target gene expression either by direct induction of transcription or by alleviating transcriptional suppression. Thus, this study not only details a broad gene expression analysis of B-cell maturation that includes our specific targets of Cr2 and Fcer2a but also incorporates analyses of other genes whose expression is similarly controlled.
Materials and methods
Mice A/J, A/WySnJ, C57BL/6 and BALB/c mice were obtained from Jackson Laboratory. C2ta (class II trans-activator)-deficient mice 39 were provided by Dr Peter E Jensen, University of Utah. All the animals were housed and bred in the Comparative Medicine Center at University of Utah Health Science Center according to the guidelines of the National Institutes of Health for the care and use of laboratory animals. Mice examined were agematched males and females, unless otherwise specified.
Antibodies
Fluorescein isothiocyanate-conjugated anti-mouse CD21 (clone 7G6), phycoerythrin (PE)-conjugated anti-mouse CD24 (clone M1/69), streptavidin (SA) PE-Cy5 (BD Phamingen, Inc., San Diego, CA, USA), biotin-and PEconjugated anti-mouse CD23 (clone B3B4) (eBioscience, San Diego, CA, USA), PE-conjugated anti-mouse AA4.1 (CD93) (eBioscience) and Cy5-conjugated polyclonal antimouse IgM (Biomedia Corporation, Foster City, CA, USA) were used for flow cytometry analyses (FACS). To-Pro-3 and 4',6-diamidino-2-phenylindole were used for viability staining (Invitrogen Corporation, Carlsbad, CA, USA).
Isolation of B-cell populations
Total splenocytes or marrow cell populations were isolated from various strains of mice at various ages as indicated in figure legends. After red blood cell lysis, a B cell-enriched population was obtained using B220 þ magnetic beads depletion according to the manufacturer's protocol (Miltenyi Biotech, Inc., Auburn, CA, USA). B220 þ cells were stained with CD21-FITC, CD24-PE, CD23-biotin/SA-PE-Cy5 or with IgM Cy5, AA4.1 PE and CD23 PE-Cy7, for flow cytometry analyses and resuspended at 5 Â 10 6 cells per ml for cell sorting. Magnetic sorting with B220 routinely provided samples 95% or greater homogeneity.
Various B-cell subsets (see Results) were sorted and isolated using FACSVantage SE at the FACS Core Facility, University of Utah. Two different approaches to isolate the T1, T2, MZ and FM splenic cells were utilized 1, 11, 40 and described in figure legends.
Microarray analyses
Total RNA was isolated from B220 þ B cells from 2-week marrow (20 animals), 2-week (four animals)-or 8-week (four animals)-old spleen from A/J, or 2-week spleen from A/WySnJ mice. Pools of cells from five mice were used per sample. Total RNA from the pools was quantified and used for Affymetrix array hybridization according to the manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). cDNA was synthesized from 5-7 mg of total RNA and hybridized to GeneChip Mouse Genome 430 2.0 Array (Affymetrix). We utilized singlechip hybridizations as duplicate chips in previous analyses showed virtually no variability. 41 To avoid skewing the data due to the health of a single animal, all grid array analyses were carried out with cells pooled from at least four genetically identical, age-matched animals. Data were processed using the Affymetrix and gcRMA (Robust Multiarray Average) packages. [42] [43] [44] Transcripts showing a change of twofold or greater were considered differentially expressed, whereas other transcripts were considered not changed. The function of gene products was primarily determined with the National Cancer Institute database, Gene Ontology annotations according to Mouse Genome Informatics and public databases such as NCBI/Pubmed and Ensembl.
RNA preparation, cDNA synthesis and real-time PCR Total RNA was isolated from cells using Illustra RNA Spin Mini kit (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's instructions. cDNA was synthesized using 2 mg of total RNA (or less in the case of isolated B-cell subsets). cDNA was purified using the Qiagen (Qiagen, Inc., Valencia, CA, USA) PCR purification kit. Quantitative real-time PCR (RT-PCR) was performed using Light Cycler (Roche Diagnostics, Indianapolis, IN USA). All shown transcript values are relative to b-actin expression and are mean values±s.d. Primer sequences for quantitative PCR analyses are listed in Table 2 . Semiquantitative RT-PCR for C2ta using P 32 -dCTP was performed as described before 45 and PhosphorImager quantification was done (STORM820 PhosphorImager and Image Quant analysis; Molecular Diagnostics, Inc., Sunyvale, CA, USA) as detailed earlier. 19 
Results
Establishing model systems for the analysis of B-cell gene expression The goal of this study was to identify those genes that are silenced or activated during splenic B-cell development, with a specific focus upon those transcription factors that might regulate the expression of the CD21 and CD23 genes in these cells. In designing such a screen, two different protocols were considered. The first approach would be to use various B-cell surface markers to purify specific subsets of marrow and splenic B cells including T1, T2, MZ and FM cells of the spleen. RNA would then be obtained from each subset and used in the grid analysis. A number of groups have taken this approach in examining gene expression profiles in subsets of immune cells. [46] [47] [48] [49] [50] There are, however, at least two major caveats to this approach.
First, the small number of cells that can be isolated using FACS sorting results in a low quantity of RNA that must be amplified to screen a grid array. The standard array process, based on having the amount of required RNA without amplification, is already biased toward preferential identification of transcripts due to abundance, size or G/C content. Addition of another linear or exponential amplification step into the process would serve to increase this bias, excluding the RNA contribution from smaller or less abundant transcripts. Other groups have documented that the sensitivity of such a screen to detect low-abundance RNA, such as those encoding transcription factors, is compromised when using limited numbers of sorted, purified cells. 51 A second caveat to this approach is that FACS sorting of cells is a time-consuming process and utilizes a variety of antibodies to identify key cell-surface proteins. These surface proteins, particularly IgM, may alter the activation state of the cell upon binding. It is possible that the RNA population present in a subset of cells after sorting is no longer representative of the RNA population that was present immediately after isolation.
A second approach would be to utilize differences in B-cell populations between various tissues and ages of mice to obtain larger numbers of cells, yielding more significant amounts of RNA and eliminating the need for further amplification steps. In this approach, magnetic beads would be used to swiftly isolate B220 þ B cells from freshly harvested bone marrow and spleen populations. Magnetic bead sorting for B220 þ cells is commonly used to purify B cells and does not directly result in their activation. [52] [53] [54] The major caveat to this second approach is that gene expression profiles obtained through this method would be representative of a mixed population of cells, not a single subset; however, by judiciously choosing the tissues to examine, we can highly enrich for specific cell populations.
As shown in Figure 1 Gene expression analysis of splenic B-cell maturation I Debnath et al sub-population of re-circulating mature B cells (CD21 þ ) as well as plasma cells; however, marrow from 2-week animals lacks these cell types as seen by the low level of CD21 expression in Figure 1 . Thus, the use of immature B cells from 2-week bone marrow, when compared with maturing or mature splenic B cells, would provide more robust data than using marrow B-cell populations from mature animals. Upon migration into the spleen, immature B cells develop into mature B cells, capable of fully expressing CD21 and CD23. For instance, in the spleens of mature animals (8 weeks), B-cell subsets can be found in the following percentages: T1 (5-10%), T2 (15-20%), MZ (3-5%) and FM (65-80%). 10 However, in younger animals, these percentages are skewed toward a more transitional, immature phenotype; at week 1, most splenic B cells are T1 but by week 2, T2 and FM B cells appear ( Figure 1 ). The mouse spleen lacks mature architecture and MZ B-cell phenotypes until 4-6 weeks postbirth. 38 Thus, comparing splenic cell populations from an 8-week animal with those of a 2-week animal would be similar to comparing mature B cells with immature B cells as those cells are predominant in the spleen at that time. In addition, comparing these two splenic samples vs the 2-week marrow B-cell sample would provide us with subsets of genes whose expression is extinguished or activated during B-cell maturation.
In addition to analyzing wild-type samples, cells obtained from mice possessing mutations that alter B-cell maturation can also be analyzed. We chose to use the second approach to examine gene expression in maturing B-cell populations because of its increased sensitivity (vs using limiting quantities of RNA isolated from aged, manipulated cells as described in the first approach) and the ability to obtain the highly enriched cell populations from the animal tissues described above. This second approach would provide us with an extensive list of possible candidate genes that could then be validated by transcript analysis from FACS-sorted B-cell subsets.
Loss of BAFF-R signaling results in a block of expression of mature B-cell immunomodulatory genes
The purpose of the first screen was to identify genes differentially expressed because of BAFF-dependent signaling by utilizing B220 þ cells from 2-week-old A/J and A/WySnJ spleens as a source of RNA for probing an Affymetrix mouse microarray. The A/WySnJ cells demonstrated altered expression of 612 probe sets (twofold or more difference over A/J samples) whereas those of A/J showed 211 probe sets (twofold or more difference over the A/WySnJ counterparts) (Supplementary Table S1 ). A selected set of genes showing differential expression in this screen is shown in Table 1 . Analysis of the genes elevated in the A/WySnJ subset indicated an abundance of genes encoding proteins involved in cell cycle arrest, apoptosis and cell division perhaps because of growth arrest induced by the loss of BAFF-R signaling. The genes demonstrating elevated expression in the A/J samples encoded many different immune response and modulation proteins indicative of the healthy maturation of B cells into the mature phenotype including the transcription factors C2ta, NFkB and Runx3. Those genes encoding B-cell proteins expressed in both T1 and T2 populations, such as CD19 or Pax5, did not show up in this array analysis indicating that the lack of BAFF signaling in the A/WySnJ sample did not significantly extinguish expression of these genes.
To confirm the differential expression of known and putative regulatory genes at the BAFF-dependent interface, quantitative RT-PCR was carried out using freshly isolated 2-week B220 þ splenocytes from A/J or A/WySnJ mice ( Figure 2 ) (Supplementary Table S2 ). CD21 (Cr2) and CD23 (Fcer2a) were used as controls and, as expected, their expression level was distinctly lower in the A/WySnJ sample. CD19 expression levels remained relatively similar between the two samples indicating, in part, that the differential gene expressions are not due to the varying number of B cells between the two populations. F4/80, a macrophage marker, was included as a control for macrophage contamination of isolated B cells. The two lower panels of Figure 2 demonstrate verification of differential gene expression between the A/J and A/ WySnJ samples. Runx3 and Gtf2i encode transcriptional regulators Sema7a, Icosl (Icos ligand), Ccr6, and Bst1 encode cell-surface proteins whereas Rsad2 encodes a cellular reductase. These profiles indicated that differences in gene expression identified in the gene grid array were confirmed by transcript analysis from independently derived A/J and A/WySnJ RNA samples.
To further analyze the expression profiles of different candidate genes obtained from the A/J vs A/WySnJ screen, we utilized RT-PCR analysis to screen mRNA samples obtained from B220 þ cells of the marrow of 2-week-old A/J animals, B220 þ splenocytes from 2-weekold A/J mice and B220 þ splenocytes from 8-week-old A/J mice. As shown in Figure 3 , CD21 (Cr2), CD23 (FceR2a), Icosl and C2ta show very similar profiles with the highest expression in the most mature B-cell subsets. A number of other genes that also demonstrated elevated expression in the A/J samples vs the A/WySnJ cells (for example, Ccr6 and Runx3) showed similar profiles to CD21. Genes that showed elevated expression in the A/ WySnJ samples, such as Tcf12, Gfi1, Erg and Bst1, had the greatest level of expression in the marrow samples and the least in the 8-week splenocyte sample. Other genes, such as Cnr2 and Sema7a, showed very similar levels of expression between the 2-and 8-week spleen samples, suggesting that their expression levels do not change during splenic B-cell differentiation. Finally, a subset of genes (typified by Rsad2) showed the greatest level of expression in the immature 2-week spleen sample compared with the mature 8-week spleen or immature marrow samples. These data confirm that the genes showing enriched expression in the A/WySnJ samples are indicative of immature/maturing B cells whereas those showing elevated expression in the A/J sample represent products of mature B cells.
Age-and maturation-dependent analyses of differential gene expression of bone marrow and splenic B-cell populations The previous set of experiments identified genes differentially expressed during BAFF-dependent splenic B-cell maturation. A number of these genes were already known to follow such expression profiles, such as Cr2 and C2ta, and thus served as positive controls. However, a number of genes not previously linked to B-cell differentiation and maturation were implicated to have a function in that process. One liability of this analysis was the inclusion of the A/WySnJ cells that are, due to the lack of BAFF signaling, inappropriately arrested in their development. Therefore, we sought to analyze similar samples from normal mice to validate candidate genes obtained from the A/WySnJ screen, as well as to identify additional genes whose expression is coincident with the transitional stage of splenic B-cell development. To accomplish this, we utilized total RNA obtained from B220 þ cells from 2-week bone marrow and compared it with RNA obtained from either B220 þ cells from 2-week or 8-week spleen (see Figure 1 and Supplementary Figure  S1 ). Affymetrix grid analysis demonstrated that 1636 probe sets demonstrated a twofold or greater expression in the marrow sample whereas 1480 probe sets demonstrated a greater than twofold expression in the 2-week spleen sample (Supplementary Table S3 ). Similarly, 1764 probe sets showed elevated expression in the marrow sample compared with 1436 probe sets in the 8-week splenocyte population (Supplementary Table S4 ). The Gene expression analysis of splenic B-cell maturation I Debnath et al gene expression profiles of the 2-week and 8-week spleens were also contrasted with each other (Supplementary Table S5 ). The 2-week spleen sample demonstrated 951 probe sets with elevated expression compared with the 8-week spleen sample, whereas 1311 probe sets are elevated in the 8-week splenic sample. Table 2 shows a subset of genes demonstrating increased expression in the B220 þ marrow population compared with the two splenocyte populations. Thus, as B cells move from the marrow to the spleen and differentiate into mature phenotypes, the expression of Cxcl4, Cxcl7 and Cxcl12 is lost, as is the expression of genes utilized in the immunoglobulin rearrangement process such as pre-B lymphocyte 1 (Vpreb1), Dntt, Rag1 and Rag2. Those genes showing virtually equivalent changes in comparing the 2-and 8-week splenocyte samples (Cxcl4, Cxcl12, Il2ra, Igfbp5, Fabp4, Ptp22, Cleg1b and Bzw2) suggest that the expression of these genes is extinguished before maturing B cells enter the spleen. However, those genes showing an enhanced expression change between the marrow and the 2-and 8-week samples (Ptpla, T2bp, Tmprss3, Bub1, Il7r, Sox4 and Tcf19) indicate that these genes are still being expressed in immature B cells but are lost in the full B-cell maturation state of the 8-week-old B220 þ splenocytes. Table 3 shows the expression profile of a subset of genes known to encode transcriptional regulatory proteins. In this table, those genes showing elevated expression in the 2-or 8-week B220 þ splenocyte populations compared with the 2-week bone marrow sample are shown. The expression patterns of this subset of genes can be divided into three general groups (Figure 4 ). Class A, typified by Mef2c, Zfp318, C2ta, Chd7, Tbx21, Stat4, Runx3 and Cbx7, demonstrated gradual increase from 2-week BM to 2-week spleen with greatest expression in the 8-week spleen sample, suggesting a required function in fully mature B cells. The second subset, class B, typified by genes Spic, Rbm5, Zfp385, Smc6 and Id2, demonstrated similar expression levels in both 2-week and 8-week subsets (compared with the marrow sample), suggesting that their expression is maximally induced as soon as the maturing B cells enter the spleen and is maintained in the mature B-cell subsets. Class C showed the highest level of expression in the 2-week splenocytes and subsequent loss in the 8-week sample. Genes of class C, such as Elf2, Gpbp1, Zfp62, Ets1 and Bptf, show the highest level of expression in B220 þ B cells immediately after migration into the spleen with diminished expression as the resident B cells take on mature phenotypes. Obviously, these classes of gene expression are not absolute, but suggest trends in gene expression profiles of this selected subset of genes encoding known, or putative, transcriptional control proteins.
To confirm the specificity of expression of a number of candidate genes identified in the screen comparing wild-type marrow and spleen samples, we utilized RT-PCR analysis using cDNA independently generated from a pool of B220 þ cells obtained from A/J 2-week marrow, and 2-week and 8-week spleens. As shown in Figure 5 , a variety of gene expression profiles were observed. Genes such as Prpf40a, Smc2 and E2f7 showed a loss of expression during B-cell maturation. Others, such as Phf1, Tbx21 (Tbet), Stat4, Mef2c, Spic, Klf12 and Hfe, demonstrated an increased expression. Supplementary Table S2 . RT-PCR, real-time PCR.
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Analyses of genes implicated in B-cell maturation using BALB/c and C57BL/6 populations The earlier analyses were performed on cell populations from the A/J mouse strain. To determine if such expression profiles were unique to the A/J strain or were strain independent, we tested the expression of candidate genes derived from the two previous gene array screens using sorted cell populations from BALB/c and C57BL/6 mice. B220 þ cells were purified from pooled samples from 2-week marrow, 2-week and 8-week spleens from the two strains and analyzed by RT-PCR. As shown in Supplementary Figure S2 , the control genes CD21 (Cr2) and CD23 (Fcer2a) showed the same expression profiles as the A/J samples (see Figure 3 ). Similar expression profiles for most of the candidate genes were obtained from cell samples derived from all three strains. A small subset of genes did show differences in expression; Spic showed depressed expression in the 8-week spleen sample for the C57BL/6 strain, and Mef2c expression in the 8-week BALB/c sample was muted. In general, the expression profiles of the B-cell maturation candidate genes were strain independent.
Defining B-cell subsets responsible for differential gene expression profiles A number of the candidate genes obtained from the previously described gene grid screens showed elevated In the first screen, we FACS-sorted cells using relative expression of CD23, CD21 and CD24 on B220 þ splenic cells to obtain T1, T2, MZ and FM populations. Gene
The expression of the CD21 (Cr2) and CD23 (Fcer2a) genes in these B-cell subsets was as expected (Figure 6b ). The expression of other genes varied widely with some showing the highest level of expression in the MZ population (Smc2, Spic and Klf12) whereas others demonstrated elevated expression in the FM population (Zfp318 and Stat4). A third subset of genes showed equivalent expression in these mature cell types (Runx3, Mef2c and Phf1). Similar screening with a number of other candidate genes (data not shown) also showed a wide variety of expression profiles indicating a high level of gene expression heterogeneity during B-cell differentiation into MZ and FM cells.
In a similar set of experiments, we utilized an alternative protocol to isolate the T1, T2, FM and MZ populations. 11, 40, 56 This protocol relies upon the differential staining of AA4.1, IgM and CD23 to resolve the B-cell subsets (Supplementary Figure S3) . AA4.1 þ cells (R3) were resolved into T1 and T2 populations by differential expression of CD23 by IgM þ cells. AA4.1À cells (R4) were separated into MZ and FM populations by the differential expression of both CD23 and IgM. RNA was isolated from the subsets and probed, by quantitative RT-PCR, for the expression of selected genes. As shown, the relative expression levels of the two control genes, CD21 and CD23, followed the expected profile and were very similar to the levels shown in the preceding Figure 6 . Similar profiles were also obtained for a number of other test genes. The data in Figure 6 and Supplementary Figure S3 indicate that genes encoding suspect transcription factors identified from the gene grid array analysis demonstrated elevated expression in more mature B cells.
Gene expression profiling of C2ta-deficient animals suggests a model of multiple developmental pathways associated with the induction of genes during splenic T1-T2 transition One difficulty in analyzing gene grid array experiments is interpreting the massive amount of information that results from performing whole genome analyses. The preceding screens have provided us with potentially hundreds of genes whose products could potentially alter B-cell maturation. Our goal is to sort these gene products into pathways that influence the expression of specific target genes such as Cr2 and Fcer2a. By utilizing known expression pathways, it should be possible to cull out previously described gene products and concentrate upon those novel gene products obtained from the Affymetrix gene arrays. One such known pathway is that of C2ta. C2ta is the master regulator controlling the expression of major histocompatibility complex class II genes. 57 As described above, the expression of C2ta was significantly induced in maturing B cells at the T1-T2 differentiation interface (coincident, for example, with Cr2 and Icosl expression) (Supplementary Figure S1) . We also observed increased expression of known C2ta target genes such as H2-Ab1, H2-DMa, H2-Ea, H2-Oa and Ctse in the 2-week and 8-week spleen (vs the 2-week marrow) Affymetrix screens. We therefore wondered if any of the novel candidate genes identified in our Affymetrix screens above were also controlled by the C2ta protein and would thus show diminished expression in a C2ta-deficient mouse. We chose B220 þ cells from 2-week-old splenocytes for this analysis because, as shown above, the 2-week wild-type spleen is enriched for transitional B cells and diminished (compared with older animals) for mature B-cell populations. B cells from C2ta-deficient mice expressed wild-type levels of CD21 and CD23 proteins (data not shown). B220 þ cells were isolated from a pool of C2ta-deficient spleens (and C57BL/6 strain-matched controls); RNA was obtained and used to screen a mouse Affymetrix gene array. Genes showing a twofold or greater difference in expression (the same threshold for the previous analyses) were considered significant (Supplementary Table S6 ). In these analyses, 357 genes were upregulated twofold or higher in C2ta-deficient cells in comparison to the WT counterpart and 95 genes were found to be elevated twofold or more in the C57BL/6 sample when compared with the C2ta mutant animal. Table 4 contains a partial list of genes identified in the C2ta analysis highlighting a subset of genes showing elevated expression in either the wild-type sample or the C2ta-deficient sample and 'genes of interest' (obtained from the previous screens) that demonstrated no difference in expression. As expected, the expression of known C2ta target genes was reduced in the C2ta-deficient sample including a variety of major histocompatibility complex class II genes. The C2ta protein has been primarily described as a transcriptional activator of class II genes; thus, it was interesting to observe that a large number of genes showed enhanced expression in the C2ta-deficient sample suggesting that the protein may also directly (or indirectly) inhibit transcription of other genes. A number of these genes showing elevated expression in the C2ta-deficient cells included those encoding cell-surface glycoproteins and blood group antigens such as Rhced (the Rhesus blood group, D antigen), Cldn13 (a member of the claudin family of 58 Therefore, the transcriptional induction of genes such as Icosl, Cr2 and others (that are coincident with C2ta expression) must be accomplished by positive induction or relaxation of suppression through transcriptional pathways yet to be elucidated.
Discussion
In this report, we have used gene grid array analysis with a variety of mouse systems to define those genes demonstrating differential expression during splenic B-cell maturation. Although the impetus of this work was to define those pathways that directly regulate the expression of Cr2 and Fcer2a, the data obtained revealed a large number of genes with differential expression during B-cell differentiation.
Our initial experiments addressed gene expression between cells arrested at the T1/T2 interface, due to the lack of BAFF signaling, with those of B cells isolated from an immature wild-type spleen. This block in differentiation in the A/WySnJ samples was confirmed by the relative loss of transcripts from the Cr2, Icosl and Bcl2 genes and the increase of transcripts encoding immature B-cell markers such as Bst1. We were initially surprised to observe the large number of cell cycle/apoptosis genes showing elevated expression in the A/WySnJ samples (Supplementary Table S1 ); however, the lack of BAFF signaling deprives B cells of a critical growth and maintenance factor predisposing them to anergy and death.
14 A number of genes showing elevated expression in the wild-type sample (compared with the A/WySnJ cells) were consistently shown to be associated with B-cell maturation and differentiation. Thus, the gene set showing elevated expression in the A/WySnJ sample included both immature B-cell products and genes induced during BAFF deprivation whereas those showing elevated expression in the A/J sample were specific for mature B-cell products.
To define additional genes showing differential expression during splenic B-cell maturation, we utilized Affymetrix analysis of A/J B220 þ cells from 2-week marrow, and 2-week and 8-week spleen samples. We chose 2-week marrow because of the paucity of mature B cells in the marrow of the immature animal. Older animals possess B220 þ CD21 þ mature B cells in the marrow either through specific retention or from blood circulation, and the presence of such cells in the marrow B-cell population would have reduced the screen's sensitivity. The 2-week spleen sample was enriched for immature splenic B cells whereas the 8-week spleen sample was highly enriched for mature B-cell types. The genes showing significantly greater expression in the 2-week and 8-week spleens compared with the 2-week marrow included many of those genes identified in the A/J vs A/WySnJ screen (enhanced in the A/J samples), as well as a number of additional candidate genes. For example, the A/WySnJ cells demonstrated an altered expression (compared with 2-week A/J B220 þ splenocytes) of 612 probe sets; of these, 221 genes also demonstrated elevated expression in the A/J bone marrow sample (compared with the 2-week and 8-week spleen samples). In addition, the A/J 2-week spleen sample showed 198 probe sets with elevated expression compared with the A/WySnJ samples. Of these 198 markers, 89 also demonstrated increased expression in the 2-week A/J spleen sample compared with the 2-week A/J marrow sample.
The primary focus of this work was to identify potential transcriptional regulators that could activate transcription of Cr2 and Fcer2a genes during splenic B-cell maturation. 19, 59 One such protein, Pax5, has been implicated in controlling Cr2 and Fcer2a expression, 23 and we have documented that Pax5 binds to the genes in vivo using mature splenic B cells. 19 Interestingly, Pax5 is also bound to these two genes as well as CD19 in immature marrow B cells that express the CD19 protein but not the CR1/CR2 or CD23 proteins, suggesting that the Cr2 and Fcer2a genes may be transcriptionally repressed in such cells.
These Affymetrix arrays have provided us with a number of transcriptional control candidate proteins whose expression nearly parallels that of Cr2/Fcer2a (thus acting as potential activators) or whose expression is opposite to that of Cr2/Fcer2a (thus potentially acting as transcriptional repressors). For example, Spic, Mef2c, Runx3, Zfp318 and Klf12 are genes that encode transcriptional control proteins whose expression is lowest in the bone marrow cells and highest in the mature B cells, and could thus serve to regulate transcription of target genes in mature B-cell types. Our data show that Spic is most highly expressed in T2 and MZ cells, with less expression in FM cells and only marginal expression in T1 cells. Spic is a member of the ets gene family and its gene product has been described as having opposing effects to PU.1 during B-cell maturation. 60, 61 Spic has also been implicated, with STAT-6, in regulating germline IgE transcription.
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Mef2c (myocyte enhancer factor 2C) has previously been defined as a transcription factor found in B cells following inflammatory stimuli. [63] [64] [65] Our data show Mef2c transcription to be evident in maturing and mature B cells, with FM cells expressing the highest levels. Mef2c was recently shown to be critical in B-cell proliferation and survival responses following antigen activation.
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Runx3 is a member of the runt domain-containing family of transcription factors that can either activate or suppress transcription. 66 Runx3 has been shown to be upregulated in maturing B cells, directly repressing the expression of Runx1. 67 Our data show that Runx3 transcription is also highest in the most mature B cells. Zfp318 encodes a zinc finger-containing protein (also known as testicular zinc-finger protein) that is implicated in spermatogenesis and potentially helps to augment or repress expression of the androgen receptor through alternative splice variants. [68] [69] [70] [71] We observe Zfp318 expression with elevated expression in FM splenic B cells (compared with marrow precursors) but low levels in MZ B cells. Finally, Klf12 is highly expressed in the most mature B cells analyzed (8-week spleen) and shows the highest expression in the MZ population. Klf12 is a member of the basic Kruppel family of transcriptional regulators and is implicated in transcriptional suppression during hematopoietic cell differentiation. [72] [73] [74] [75] Another set of genes encoding transcriptional regulators are progressively downregulated during the transitional maturation of B cells and thus may allow the expression of genes in mature B cells (by alleviating transcriptional repression) or result in the loss of proteins expressed in immature B cells (loss of positive regulation). For example, the genes Tcf12, Gfi1, Erg and E2f7 show the highest level of expression in the B220 þ marrow cells with declining expression in the most mature B cells. Tcf12 (also known as HeLa E-box-binding protein) is a member of the E-protein family of transcription factors that can form heterodimers with basic helix-loop-helix proteins. 76, 77 Animals lacking the Tcf12 protein die soon after birth but do show normal B-cell development. 78 Animals lacking both Tcf12 and E2A, however, show a more profound B-cell defect than either mutation alone, suggesting that B-cell development requires a combined dosage of E2A and Tcf12. 78 The specific gene targets of Tcf12 in maturing B cells is not known although CD4 is a target of Tcf12 control in T cells. 79 The Gfi1 gene encodes a SNAG domain-containing zinc finger transcriptional repressor that has been implicated in T-cell development and growth, the differentiation of neutrophils and immature hematopoietic stem cell differentiation. [80] [81] [82] [83] Animals lacking Gfi1 show reduced numbers of B220 þ marrow cells, which has been shown to be because of reduced expression of, and signal transduction from, the IL-7R. 84 Erg is in the Erg/Fli-1 subfamily of the ets gene family of transcription factors. 85 The ERG protein has been most highly studied in the development of cartilage formation in chick embryos: its potential role in B-cell development is unknown. 86, 87 E2f7 is a member of the E2F transcription factor family that includes a number of transcriptional activating and repressing proteins (E2F7) that regulate cell cycle progression and activation (suppression) of target genes. [88] [89] [90] [91] Its role in immature B-cell development is not known.
The description above of only a small subset of transcriptional regulators identified in these gene grid array screens indicates that our list of candidate genes includes those genes with a known role in B-cell development and function, and a large subset of genes for which no such role(s) has been identified. Using conditional animal knockout models, anti-sense/overexpression assays and chromatin immunoprecipitation assays, the functions of these proteins involved in B-cell development can be elucidated and the genes they regulate be identified.
